Advanced search
Start date
Betweenand

Pharmacokinetic/pharmacodynamic (PK/PD) model on the influence of genetic polymorphism of cytochrome P450 (CYP 2C9) of nonsteroidal anti-inflammatory and major metabolites from saliva samples by LCMS / MS and its role in the prescription customization